I 
116TH CONGRESS 
2D SESSION 
H. R. 6879 
To enhance American production of certain medical supplies, and for other 
purposes. 
IN THE HOUSE OF REPRESENTATIVES 
MAY 14, 2020 
Ms. SLOTKIN (for herself and Mr. VAN DREW) introduced the following bill; 
which was referred to the Committee on Energy and Commerce, and in 
addition to the Committee on Oversight and Reform, for a period to be 
subsequently determined by the Speaker, in each case for consideration 
of such provisions as fall within the jurisdiction of the committee con-
cerned 
A BILL 
To enhance American production of certain medical supplies, 
and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Buy American Medical 
Supply Chain Act of 2020’’. 
VerDate Sep 11 2014 
16:07 Jun 05, 2020
Jkt 099200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H6879.IH
H6879
pamtmann on DSKBC07HB2PROD with BILLS
SEC. 2. ENHANCING AMERICAN PRODUCTION OF CERTAIN 
MEDICAL SUPPLIES. 
(a) IN GENERAL.—Notwithstanding section 1907 of 
title 41, United States Code, a commercially available off- 
the-shelf item procured for the Strategic National Stock-
pile under section 319F–2 of the Public Health Service 
Act (42 U.S.C. 247d–6b) shall be considered manufac-
tured in the United States for the purposes of section 
8302 of title 41, United States Code, if— 
(1) the item is manufactured in the United 
States; and 
(2) the cost of all the components of such item 
manufactured in the United States exceeds 50 per-
cent of the cost of all the components of such item. 
(b) APPLICABILITY.—Subsection (a) applies with re-
spect to the procurement of items on or after the date 
that is 90 days after the date of the enactment of this 
Act. 
(c) DEFINITION.—In this section, the term ‘‘commer-
cially available off-the-shelf item’’ has the meaning given 
that term in section 104 of title 41, United States Code, 
except that such term does not include an item that is 
a drug, vaccine, or other biological product (as such terms 
are used in section 319F–2 of the Public Health Service 
Act (42 U.S.C. 247d–6b)). 
VerDate Sep 11 2014 
16:07 Jun 05, 2020
Jkt 099200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H6879.IH
H6879
pamtmann on DSKBC07HB2PROD with BILLS
SEC. 3. PROGRAM TO MAINTAIN AMERICAN SURGE PRO-
DUCTION CAPACITY. 
(a) IN GENERAL.—The Secretary of Health and 
Human Services shall establish and implement a program 
to maintain United States industrial production capacity 
for items in the Strategic National Stockpile under section 
319F–2 of the Public Health Service Act (42 U.S.C. 
247d–6b) at a level needed to ensure that domestic needs 
can be met during a surge in worldwide demand due to 
a pandemic or other widespread emergency. 
(b) AUTHORIZATION
OF APPROPRIATIONS.—There 
are authorized to be appropriated— 
(1) $25,000,000 for the period of fiscal years 
2020 and 2021 to design the program under this 
section; and 
(2) $500,000,000 for each of fiscal years 2021 
through 2031 to carry out the program under this 
section. 
Æ 
VerDate Sep 11 2014 
16:07 Jun 05, 2020
Jkt 099200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\H6879.IH
H6879
pamtmann on DSKBC07HB2PROD with BILLS